Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia

por Brandao, L N, Winges, A, Christoph, S, Sather, S, Migdall-Wilson, J, Schlegel, J, McGranahan, A, Gao, D, Liang, X, DeRyckere, D, Graham, D K
Publicado 2013

A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop

por Ware, K E, Hinz, T K, Kleczko, E, Singleton, K R, Marek, L A, Helfrich, B A, Cummings, C T, Graham, D K, Astling, D, Tan, A-C, Heasley, L E
Publicado 2013

Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia

por Lee-Sherick, A B, Eisenman, K M, Sather, S, McGranahan, A, Armistead, P M, McGary, C S, Hunsucker, S A, Schlegel, J, Martinson, H, Cannon, C, Keating, A K, Earp, H S, Liang, X, DeRyckere, D, Graham, D K
Publicado 2013

Erratum: Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia

por Lee-Sherick, A B, Eisenman, K M, Sather, S, McGranahan, A, Armistead, P M, McGary, C S, Hunsucker, S A, Schlegel, J, Martinson, H, Cannon, C, Keating, A K, Earp, H S, Liang, X, DeRyckere, D, Graham, D K
Publicado 2016